May 30, 2014 tranexamic acid is a transstereoisomer of 4aminomethylcyclohexanecarboxylic acid and has a molecular weight of 157. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in tr auma patients with sig ni. With strong affinity for the five lysinebinding sites of plasminogen, tranexamic acid competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis. Identification of the substancemixture and of the companyundertaking 1. Tranexamic acid ta with a molecular weight of 157 gmol, water solubility 1. Wo2015104721a2 an improved process for the preparation of. Tranexamic acid 500 mg filmcoated tablets tranexamic acid read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Tranexamic acid tablets are for oral administration only. The biological halflife of tranexamic acid in the joint fluid is about three hours. Prior to prescribing lysteda, exclude endometrial pathology that can be associated with heavy menstrual bleeding. Hazardous in case of skin contact irritant, of eye. Pfizer inc believes that the information contained in this material safety data sheet is accurate, and while it is provided in good faith, it is without warranty of any kind, expressed or implied. Relevant identified uses of the substance or mixture and uses advised against 1.
This inhibits the process of fibrinolysis in addition to the protein breakdown caused by plasmin. Tranexamic acid diffuses rapidly into joint fluid and the synovial membrane. There is no evidence from animal studies that tranexamic acid has any teratogenic effect, however, the usual caution with use of drugs in pregnancy should be observed. Show this safety data sheet to the doctor in attendance. Material safety data sheet tranexamic acid msds section 1. Tranexamic acid is a synthetic derivative of the amino acid lysine. Tranexamic acid is a competitive inhibitor of plasminogen activation and at much higher concentrations a noncompetitive inhibitor of plasmin, thus implying that tranexamic acid interferes with the fibrinolytic process in the same way as aminocaproic acid. Use this medicine tranexamic acid tablets as ordered by your doctor. Tranexamic acid side effects, dosage, interactions drugs. Cases of allergic reaction with use of intravenous tranexamic acid, including anaphylaxis or anaphylactoid reaction have been reported that are suggestive of a causal relationship.
Plasmin also has inflammatory and neurotoxic effects. Some include changes in color vision, blood clots, and allergic reactions. Table 1 patient characteristics parameter tranexamic acid n. Because animal reproduction studies are not always predictive of human response, tranexamic acid should be used during pregnancy only if clearly needed. Tranexamic acid is a synthetic derivative of the amino acid lysine and binds the 5 lysine binding sites on plasminogen. Tranexamic acid for the treatment of heavy menstrual. This mouthwash is used for patients who take blood thinning medications such as warfarin. Lysteda tranexamic acid tablets is an antifibrinolytic indicated for the treatment of cyclic heavy menstrual bleeding. In hospital, your child may be given tranexamic acid as an injection into their vein. Tranexamic acid is trans4aminomethylcyclohexanecarboxylic acid and is a competitive inhibitor of plasminogen activation and, at much higher concentrations, a noncompetitive inhibitor of plasmin. A mouthwash solution may also be given, for example after a dental procedure or ollowing a mouth bleed. The last bolus dose is to be administered 16 hours after the initial dose.
Product monograph cyklokapron 500 mg tranexamic acid tablets. Tranexamic acid mouthwash is used after surgery to stop active bleeding from surgical wounds, ie. If inhaled if breathed in, move person into fresh air. Tranexamic acid injection fda prescribing information.
These patients are at risk of bleeding for too long, as warfarin and some other medications prevent the natural clotting process. Tranexamic acid injection fda prescribing information, side. Tranexamic acid txa is a competitive inhibitor of plasminogen activation through the formation of a reversible complex displacing plasminogen from fibrin. Antifibrinolytic a competitive inhibitor of plasminogen activation and at much higher concentrations a noncompetitive inhibitor of plasmin, thus implying that tranexamic acid interferes with plasminogen not allowing fibrin to activate or plasmin to form therefore decreasing the. In the joint fluid, the same concentration is obtained as in the serum.
This compound appears to interfere with the fibrinolytic process in the same way as aminocaproic acid. Buy cistranexamic acid 1197177, an antifibrinolytic agent. Tranexamic acid is eliminated by glomerular filtration, excretion being about 30% at one hour, 55% at three hours and 90% at 24 hours after intravenous administration of 10 mg per kg body weight. If data for a hazard are not included in this document there is no. Pdf tranexamic acid for treatment and prophylaxis of. Solutions diluted to 2% tranexamic acid, may be administered at 2. List of drug master files dmf of tranexamic acid active pharmaceutical ingredient api submitted to the u.
Tranexamic acid cyklokapron for use in the trauma patient drug class. Tranexamic acid is a synthetic derivative of the amino acid lysine with antifibrinolytic activity. Page 37 safety data sheet according to 19072006ec, article 31 printing date 29. Only select registry of toxic effects of chemical substances rtecs data is presented here. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Description of first aid measures firstaid measures general. Tranexamic acid will counteract the thrombolytic effect of fibrinolytic preparations.
Tranexamic acid is a transstereoisomer of 4aminomethylcyclohexanecarboxylic acid and has a molecular weight of 157. After oral administration of 1015 mg per kg body weight, excretion was 1% at one. Lysteda tranexamic acid tablets is indicated for the treatment of cyclic heavy menstrual bleeding see. Tranexamic acid, when given from 6 days to 1 year, has been shown to cause local areas of retinal degeneration in cats, dogs, and rats following oral or intravenous administration at doses between 6 to 40 times the recommended human dose. Tranexamic acid injection safety data sheet sds effective date. This inhibits plasmin formation and displaces plasminogen from the fibrin surface. Cyclohexanecarboxylic acid, 4aminomethyl, trans inci name. It reduces menstrual blood loss mbl by 26%60% and is significantly more effective than placebo, nonsteroidal antiinflammatory drugs, oral cyclical luteal phase progestins, or oral etamsylate, while the levonorgestrelreleasing intrauterine system reduces mbl more. Tranexamic acid crs safety data sheet safety data sheet in accordance with regulation ec no. Tranexamic acid has proven to be an effective treatment for heavy menstrual bleeding hmb. The concentration of tranexamic acid in a number of other tissues is lower than in blood. It belongs to a class of drugs known as antifibrinolytics. It is taken either by mouth or injection into a vein.
Tranexamic acid is an antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. See actual entry in rtecs for complete information. Your new online msds binder is a place for you to store the material safety data sheets you need to deploy. Never give anything by mouth to an unconscious person. Uses of tranexamic acid bja education oxford academic. Tranexamic acid 1197188 2148182 not listed not listed 500 mg talc nonasbestiform 14807966 2388779 not listed not listed silicon dioxide, nf 7631869 2315454 not listed not listed magnesium stearate 557040 2091503 not listed not listed microcrystalline cellulose 9004346 2326749 not listed not listed. Sep 01, 2019 tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i. In general, tranexamic acid loading doses are diluted in 50 to 250 ml of glucose or 0. Tranexamic acid injection, 100 mgml american regent. Wo2015104721a2 an improved process for the preparation. Do not take this medicine tranexamic acid tablets for longer than you were told by your doctor. Tranexamic acid investigated as a drug and reproductive effector. Tranexamic acid prevents enzymes in the body from breaking down blood clots. It is taken either by mouth or injection into a vein side effects are rare.
Tranexamic acid cyklokapron for use in the trauma patient. Safety data sheet tranexamic acid injection, usp apollo. Tranexamic acid injection, 100 mgml safety data sheet according to federal register vol. Tranexamic acid txa is a medication used to treat or prevent excessive blood loss from major trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation. Apr 15, 2019 tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i. Pronunciation of tranexamic acid with 1 audio pronunciation, 1 meaning, 8 translations and more for tranexamic acid. Lysteda tranexamic acid dose, indications, adverse. Sigmaaldrich offers a number of tranexamic acid products. Nov 09, 2018 tranexamic acid is a manmade form of an amino acid protein called lysine. Dec 31, 2019 use this medicine tranexamic acid tablets as ordered by your doctor.
If data for a hazard are not included in this document there is no known. Australian public assessment report for tranexamic acid. If you have any further questions, ask your doctor or pharmacist. Tranexamic acid works by slowing the breakdown of blood clots, which helps to prevent prolonged bleeding. Hazard pictograms ghsus potential acute health effects. Active thromboembolic disease such as deep vein thrombosis, pulmonary embolism and. The product is intended for research, analysis and scientific. Tranexamic acid solution for injection molecular weight. Lysteda tranexamic acid dose, indications, adverse effects. Tranexamic acid is an antifibrinolytic agent, and concomitant use can further exacerbate the thrombotic risk associated with these estrogencontaining hormonal products.
Webmd provides common contraindications for tranexamic acid oral. This msds above is believed to be accurate and represents the best information currently available to us. Cyklokapron tranexamic acid page 6 of 22 convulsions have been reported in association with tranexamic acid treatment. Tranexamic acid side effects, dosage, interactions. Tranexamic acid is frequently used in surgeries with high risk of blood loss such as cardiac, liver, vascular. The process can be performed at moderate reaction conditions such as at moderate temperatures and moderate pressure for large scale manufacture of tranexamic acid. Tranexamic acid transamin is an antifibrinolytic for blocking lysinebinding sites of plasmin and elastasederived plasminogen fragments with ic50 of 5 mm. Tranexamic acid in sodium chloride, injection, solution, 10 mg1ml, intravenous, exela pharma sciences, llc, 20190601, not applicable. An improved process for the preparation of tranexamic acid is disclosed. Tranexamic acid is a manmade form of an amino acid protein called lysine. Find out what health conditions may be a health risk when taken with tranexamic acid oral. Tranexamic acid is a competitive inhibitor of plasminogen activation, and at much higher concentrations, a noncompetitive inhibitor of plasmin, i. Tranexamic acid n 25 placebo n 22 figure 1 flowchart of participants recruitment. Because animal reproduction studies are not always predictive of human response, tranexamic acid should be used during pregnancy only if.
61 500 501 1255 1585 1453 859 1530 6 110 656 412 27 837 215 80 657 1347 609 358 383 1355 1301 199 736 781 1310 1304 1407 1189 5